AbbVieMEX:ABBV +2.31%72 Market Cap is MXN7,841,493 Mil as of Jun. 27, 2026. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,624.05 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,023 Drug Manufacturers companies, AbbVie ranks better than 99.71% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AbbVie's share price for the quarter that ended in Mar. 2026 was MXN3761.01. AbbVie's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,767 Mil. Therefore, AbbVie's market cap for the quarter that ended in Mar. 2026 was MXN6,644,697 Mil.
AbbVie's quarterly market cap
declined
from Sep. 2025 (MXN7,446,570 Mil) to Dec. 2025 (MXN7,265,210 Mil) and
declined
from Dec. 2025 (MXN7,265,210 Mil) to Mar. 2026 (MXN6,644,697 Mil).
AbbVie's annual market cap
increased
from Dec. 2023 (MXN4,614,227 Mil) to Dec. 2024 (MXN6,388,306 Mil) and
increased
from Dec. 2024 (MXN6,388,306 Mil) to Dec. 2025 (MXN7,265,210 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AbbVie's Enterprise Value for Today is MXN8,954,087 Mil.
AbbVie (MEX:ABBV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AbbVie Market Cap Related Terms
AbbVie Market Cap Historical Data
* Premium members only.
The historical data trend for AbbVie's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, AbbVie's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's Market Cap distribution charts can be found below:
* The bar in red indicates where AbbVie's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AbbVie's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie (MEX:ABBV) has a Market Cap of MXN7,841,493 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AbbVie and its competitors. According to the industry distribution chart, AbbVie ranks #3 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 0.3%.
Is AbbVie's Market Cap too high?
AbbVie's current Market Cap is MXN7,841,493 Mil. Based on the distribution chart, AbbVie ranks #3 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Market Cap compare to MRK and JNJ?
According to the Drug Manufacturers industry distribution chart, AbbVie ranks #3 out of 1023 companies for Market Cap. This places AbbVie in the top 0% of its industry — outperforming the majority of peers. The industry median Market Cap is 205.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AbbVie and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AbbVie's current Market Cap is MXN7,841,493 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,624.05, compared to a current price of MXN4,343.00 — trading 19.8% above its estimated fair value. The current Market Cap is MXN7,841,493 Mil. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current Market Cap is MXN7,841,493 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AbbVie (MEX:ABBV) Overvalued in 2026?
Based on GuruFocus' analysis, AbbVie stock appears to be overvalued.
The current stock price of MXN4,343.00 is trading 19.8% above its estimated GF Value™ of MXN3,624.05.
GuruFocus considers AbbVie to be Modestly Overvalued.
Key valuation signals for MEX:ABBV:
Market Cap: MXN7,841,493 Mil
GF Value™: MXN3,624.05 vs. price of MXN4,343.00 (19.8% above fair value)
No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score
Get the complete analysis for MEX:ABBV
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABBV has been successfully added to your 
